$SLNO News Article - Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome https://marketwirenews.com/news-releases/sole...54137.html
(0)
(0)
Soleno Therapeutics, Inc. (SLNO) Stock Research Links